Global Melanoma Therapeutics Market Size Worth Over 4.63 Billion by 2 Global Melanoma Therapeutics Market Size Worth Ove | Page 2

According to the report “Global Melanoma Therapeutics Market", published by Market Data
Forecast, the global market is projected to reach USD 4.63 billion by 2021, at a CAGR of
15.80% from 2016 to 2021.
Melanoma is a highly heterogeneous disease including Ocular Melanoma (OM), Cutaneous
Melanoma (CM), Mucosal Melanoma (MM), melanoma of the internal organs, and,
according to some classifications, melanoma of the soft parts of the body (non-bony and
non-cartilaginous tissues). Melanoma denotes to the type of skin cancer which forms from
the pigment-consisting cells in the skin.
Free Sample for report: http://www.marketdataforecast.com/market-reports/global-
melanoma-therapeutics-market-850/request-sample
It is more frequent in places with a sunny environment and is the most dangerous of all skin
cancers. UV radiations are the main causes of melanoma. The high demand of novel early
stage and advanced melanoma therapies along with a booming patient base, has created an
impending need for improving therapies in the melanoma market However, genes can also
lead to melanoma. Treatments accessible for melanoma include surgery, radiation therapy,
immunotherapy, and chemotherapy. Large uptake of these novel treatments is expected
due to their improved survival benefits and minimal side effects.
The factors affecting the Global Market for Melanoma Therapeutics Market, either
positively or negatively are presented in the DROC analysis. Some of the things discussed in
the section are rise in melanoma cases, increasing awareness, high acceptance rate of
therapeutics among patients, and government policies to provide better care for melanoma.
However, high costs incurred due to treatments and poor availability of proper cancer care
in the emerging regions are hindering the growth of the market.
For granular level understanding the Melanoma Therapeutics Market is segmented based
on the following categories with Market Size Estimations and Y-o-Y Forecasts presented for
each sub-segment.
By cancer stage:





Stage 0
Stage I
Stage II
Stage III
Stage IV
By cancer type:




Nodular melanoma
Acral lentiginous melanoma
Superficial spreading melanoma
Lentigno maligna melanoma